EcoDrugPlus

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSAPEG00000023658
Gene Symbol: SLC6A4A
1 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSAPEG00000019159
Gene Symbol: SLC6A9
1 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3, Tandem Duplicate 2

Ensembl ID : ENSAPEG00000020397
Gene Symbol: SLC9A3.2
1 Cross references
237 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSAPEG00000002188
Gene Symbol: SSTR1
1 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSAPEG00000003192
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSAPEG00000019588
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSAPEG00000013443
Gene Symbol: SYK
1 Cross references
203 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSAPEG00000015026
Gene Symbol: SRD5A2A
1 Cross references
208 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSAPEG00000023353
Gene Symbol: SRD5A2B
1 Cross references
192 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSAPEG00000002504
Gene Symbol: SOAT1
1 Cross references
211 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSAPEG00000000456
Gene Symbol: TACR1
2 Cross references
214 Possible Orthologues:

Tachykinin Receptor 1b

Ensembl ID : ENSAPEG00000007768
Gene Symbol: TACR1B
1 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).